- The week in hospital M&A
- FDA approves new class of multiple myeloma drug
- Is the behavioral health access problem actually a quality problem?
- Is the behavioral health access problem actually a quality problem?
- Westchester Medical Center names chief medical officer
- Strengthening the backbone of care: 7 rural workforce transformation strategies changing the labor landscape
- Ochsner Health back in the black through H1
- PA pay by specialty: cardiothoracic, vascular surgery top $162K
- Nurses at SSM Health outpatient practices move to unionize
- 6 recent hospital, health system CFO moves
- 62% of ASCs cancel, delay cases over anesthesia gaps
- The secret to success behind the top 1% of American hospitals
- Processed Foods Linked To Prostate Cancer Risk
- Novant Health gets North Carolina OK to build $324M hospital
- Screen Time Is Not All Bad For Kids' Brains
- Winter Is Coming: How Vaccines Help Protect Against Respiratory Illness
- Updated Statement Regarding the Division of Corporation Finance’s Role in the Exchange Act Rule 14a-8 Process
- Sleep Disturbances Linked To Genetic Alzheimer's Risk
- Pre-K Sets Kids Up For School Success, Study Says
- Expect Other Seniors To Act Their Age? Then Expect Problems With Your Own Memory, Study Says
- People With Disabilities Say Medicaid Income Limits Stifle Career Advancement
- A genomics library for the AI era
- BMS bags first FDA approval for CELMoD franchise with Zenbexus multiple myeloma nod
- Trump Team’s Use of Arcane Budget Rule Threatens Medicaid Coverage
- My Husband Was Kicked Out of Hospice for Dying Too Slowly
- Massachusetts moves to restrict kratom sales
- Meet the leaders of the fastest-growing dental practices
- Fierce Pharma Asia—Legend’s first profit; Taiho, Cullinan’s EGFR win; WuXi AppTec’s reprieve
- Will cardiology’s ASC strategy pay off? CVL’s new CEO is betting on it
- 5 numbers making dentists optimistic
- 25 state behavioral health policy updates
- Wisconsin woman accused of posing as fake dentist ordered to pay customer $144K
- Physician independence is making a comeback — why ASCs are leading the way
- Surgery Partners is betting on physician recruiting, not M&A, for growth: 5 things to know
- Dentists battle insurance woes: 5 updates
- Philadelphia dentist dies at 86
- 4 injured after car crashes into North Carolina pediatric dental office
- Ellis Hospital sues St. Peter’s over cardiologist noncompetes, warns of $75M revenue risk
- Mental healthcare provider gaps, by state
- Park Dental Partners posts $66.2M in Q2 revenue
- 28 new behavioral health study findings to know
- 23 new behavioral health projects to know
- Which services are hit hardest by CON?
- 5 gastroenterologists in the headlines
- Where spine, orthopedic ASCs are gaining ground
- Aspen Dental continues 2026 growth with new Chicago practice
- Major PBMs agree to offer TrumpRx pricing information to members
- Distalmotion gets FDA clearance for hernia repair system
- Providence reports $400M operating improvement halfway through 2026
- A look at where Aetna is seeing value-based care success in Medicare Advantage
- Nationwide program to quit smoking would save US $12B: Study
- Rare Bacteria In Coastal Waters Has Killed 7 This Summer
- Angelalign to appeal court’s decision in clear aligner patent infringement case
- It's crunch time for Karyopharm as company faces potential default next month
- UNC Health Pardee completes 23-bed behavioral health center
- Oregon State Hospital superintendent out after less than a month
- Affordable Care completes recapitalization, enters ‘next chapter’ of growth
- March of Dimes: Maternity care deserts persist, Medicaid cuts threaten to curb access further
- Trump administration refers scores of providers, pharmacies, PBMs to DOJ, OIG over past billing for pediatric gender-affirming care
- Socializing: A Prescription For Healthier Brain Aging
- Taking The Stairs May Lower Your Risk Of Dying From Heart Disease
- Obesity not a 'zero-sum game' as patients crave optionality, Novo CEO says: Reuters
- AZ's blood pressure newcomer Baxfendy fails to meet cost-effectiveness bar, ICER says
- Sweet Tooth? It Could Be Shaping Your Decisions, Study Says
- Stressed Parents Turn To Screens For Help, Study Finds
- Gambling Linked To Mental Health Problems Among College Students
- Hospitals Say They Found A Tool To Help Reduce Childbirth Risks: Wristbands
- Listen to the Latest ‘KFF Health News Minute’
- People With Disabilities Say Medicaid’s Limits on Income Stifle Career Advancement
- Readers Speak Out on Work Requirements, Federal Data Grab, Opioid Payback Cash
- Abbott to pump up blood supply with $1M college sports prize amid US crisis
- Federal agencies release ‘Treatment First’ toolkit
- Neurocrine stands by blockbuster hopeful Vykat XR as Prader-Willi docs raise potential safety flags
- Appeals court tosses methodology for calculating NSA qualifying payment amounts
- UC San Diego Health, West Health launch $40M accelerator for 'tech-forward' coordinated care
- Epic releases Care Everywhere diagnostic image exchange to tackle healthcare's 'CD problem'
- FDA Wants More Information From Food Makers On New Food Chemicals
- Cityblock unveils partnership with Humana in North Carolina
- Antelope Recovery, offering SUD care for teens, to expand Spanish services in Colorado
- Legend interim CEO talks rising competition as Carvykti maker posts first profit
- Aspirin/Omega-3 Combo Matches Antibiotics In Treating Gum Disease, Trial Finds
- Endometriosis Linked To Higher Type 2 Diabetes Risk
- Cedar launches Kora Platform to build out agentic AI for medical billing
- Sharp HealthCare announces another reorganization affecting 260 workers
- Alfasigma gains arthritis drug, access to new markets with M&A play
- Common Health Coalition secures $100M from OpenAI Foundation to boost hepatitis C cure rates
- Lilly takes 6 companies to court for selling retatrutide knockoffs
- Tamiflu Helps Keep Severely Ill Kids Out Of The ICU, Study Finds
- 'Normal' Can Backfire During Doctor/Patient Discussions
- Experimental Pulse Oximeter Accurate Regardless Of Skin Tone, Researchers Say
- Suvi Health launches ambient AI solution for patients to reduce hospital stays and support care transitions
- The biggest payer and provider trends from Q2
- Patients Wary Of Governments, Companies Pushing AI As A Rural Healthcare Solution
- Hospital Prepayment Requirements Add New Wrinkles to Patients’ Financial Responsibility
- Hospitals Say They Found a Tool To Help Reduce Childbirth Risks: Wristbands
- Years After He Quit Smoking, a Lung Cancer Scan Saved His Life
- Fresenius pulls one batch of Actemra biosim over glass particle concerns
- Oracle Health debuts revamped patient portal with an AI upgrade
- Snapchat creates ad format to support pharma disclosure needs
- CMS ends Medicaid, CHIP funding for gender-affirming care for minors
- Healthcare CFOs face growing decision-making expectations. Many say they aren't ready
- Assort Health rolls out AI agent to automate referrals for specialty practices and health systems
- Claims data transparency empowers employers to act on affordability: survey
- Hims & Hers posts $753M in Q2 revenue as it preps for push into peptide market
- Executive Order Calls For Fewer Routine Childhood Vaccines, Doctors Push Back
- Biopharma saw a Q2 sales boom led by Lilly, Sanofi, Regeneron and Astellas
- Real-World Performance Of Alzheimer's Drug, Leqembi, Matches Trial Data, Study Finds
- Study Finds Undisclosed Chemicals In Most Personal Care Products
- Senators introduce bipartisan legislation to further antimicrobial resistance research
- CMS' mandatory VBC programs brought substantial administrative costs for hospitals: study
- Flagler Health secures $50M series B for AI-native MSK care platform expansion
- Attruby cruises toward blockbuster land as BridgeBio CEO spots ‘stabilizer-first’ ATTR market
- WuXi AppTec scores temporary win amid fight over DOD's Chinese military company brand
- Barbie And Ken Fade From Fantasy, Offer More Realistic Proportions, Study Finds
- Children Should Get Flu Vaccine, Top Pediatrics Group Recommends
- Together, Two Everyday Health Factors Double Death Risk In Midlife And Beyond
- Many States Cover Doula Care, But Access To A 'Birthing Bestie' Is Often Out Of Reach
- Patients Wary of Governments, Companies Pushing AI as a Rural Healthcare Solution
- A Federal Policy Is Complicating How Organizations Battle the Opioid Crisis
- Chairman Paul S. Atkins Letter to Robert Walley, Chair, CAT NMS Plan Operating Committee
- Trump signs executive order to overhaul pediatric vaccine recommendations
- Unapproved in US for decades, levosimendan stumbles in phase 3 as Tenax eyes narrow FDA path
- Jalapeño Recall Reaches Seven Grocery Chains In 26 States
- New Melanoma Drug, Tudriqev, Based On Herpes Virus Granted FDA Accelerated Approval
- Even Light Exercise May Lower Stroke Risk For People With A-fib
- Working At Home Makes Breastfeeding Harder, Not Easier, Study Says
- Kidney Dialysis: Here's What You Need To Know
- What 524B and QMSR Change About Medical Device Risk
- Taking Lean Manufacturing to the Next Level
- Why Few MedTech Sales Teams Are Using AI Where It Matters Most
- ITM neuroendocrine tumor drug spurned by FDA over manufacturing qualms
- Abbott casts telenovela star Gabriela Spanic to take the drama out of colon cancer screening
- Bristol Myers Squibb lays out plan for $2.3B manufacturing facility in Houston
- Scholar Rock ditches Novo’s legacy Catalent plant in FDA refiling of SMA drug
- Zepbound Lowers Heart Attack, Stroke Risk Among Type 2 Diabetics
- Heart Problems Linked To Brain Shrinkage Among People With Genetic Risk For Alzheimer's
- Budget Battle Erupts In Nation's Capital Over Opioid Settlement Money
- Rising Global Heat Linked To Mental Health Risks In Children
- Quanterix hires GE Healthcare, Exact Sciences alum as chief commercial officer
- Why Organizations Miss Emerging Product Risk: Understanding the engineering mechanisms that remain hidden long before complaint trends become visible
- Update on the SEC’s Work Toward Treasury Clearing Implementation [August 2026]
- FDA Reverses Course, Approves First mRNA Flu Shot
- Therapy Dogs Aid Stroke Rehab
- Can Yoga Calm A Grumpy Gut?
- Leo Pharma readies rare disease education push for 2nd annual GPP awareness day
- The Interface is the Risk: A MedTech Blueprint for AI and System Integration
- Restoring Regulatory Clarity: Statement on Technical Amendments to Rule 0‑1(a)(7)
- Beyond the Status Report: Using LLMs to Reveal the True State of SaMD Development
- Headstands and Summervaults: A Statement on Crypto Vaults and Lending Strategies
- Remarks at the Small Business Capital Formation Advisory Committee Meeting
Michigan healthcare freedom community forum
Dr. Erica Schwartz, a former Deputy Surgeon General, will probably not be confirmed to lead the Centers for Disease Control and Prevention (CDC). Neither will Sean Kaufman, nominated to head the HHS Administration for Strategic Preparedness and Response (ASPR). The Administration for Strategic Preparedness and Response (ASPR) is a U.S. Health and Human Services (HHS) agency which responds to public health emergencies and disasters. It manages the Strategic National Stockpile (United States' national repository of antibiotics, vaccines, chemical antidotes, antitoxins, etc.) and the Biomedical Advanced Research and Development Authority (BARDA).
Defeated RINOs and Democrats are making these nominations their political statements, before November 3rd:
https://thehill.com/policy/healthcare/5970727-schwartz-kaufman-cdc-aspr-testimony/
Cassidy, Senate Democrats grill Trump health nominees over vaccine pressures
By Joseph Choi - July 15, 2026Two of President Trump’s most recent health nominees, including his newest pick to be head of the Centers for Disease Control and Prevention (CDC), appeared before the Senate on Wednesday where a reluctance to break with the administration put Democrats and some Republicans on edge.
Erica Schwartz, nominee to be the next director of the CDC; and Sean Kaufman, nominee to head the Administration for Strategic Preparedness and Response (ASPR); both appeared before the Senate Committee on Health, Education, Labor and Pensions (HELP), where key lawmakers sought out reassurances that both nominees would be able to resist political interference if confirmed.
As a longtime physician and former deputy surgeon general under the first Trump administration, Schwartz represented a more mainstream pick to head the CDC. The agency has gone without steady leadership throughout Trump’s second term, with his second choice — veteran government scientist Susan Monarez — being pushed out of the role less than a month after she was confirmed.
Kaufman, currently a senior adviser for global affairs at the CDC, spent a significant portion of his testimony defending or clarifying past remarks critical of vaccine policy.
With infectious disease concerns abounding domestically, and cases of measles and cyclosporiasis continuing to spread across the country, lawmakers are anxious to get solid leadership into place at the CDC and ASPR. But issues that cast doubt on previous Trump health nominees came up once again on Wednesday.
Cassidy left wanting
Sen. Bill Cassidy (R-La.), chair of the Senate HELP Committee, made his reservations clear throughout the hearing Wednesday, at various points expressing disappointment and ire with the answers he got from both Schwartz and Kaufman.
Having lost his reelection bid in May, Cassidy was unrestrained from pressures to appease the administration. He made it clear at the start of the hearing that he wanted nominees who could rebuild trust in public health.
Given that Monarez claimed she was fired as CDC director for refusing to grant carte blanche approval to vaccine policy changes without seeing the evidence, Cassidy questioned whether Schwartz would stand up to the administration over policies that she believed would be wrong for public health.
“The one thing that I can tell you is how I lead and how I live, and I have lived and I have led by my integrity,” Schwartz told Cassidy. “I have spent over 25 years in the uniformed services, leading by integrity. That is what I can commit to you and to the committee. That I will continue to live and lead by my integrity. You are a physician. I’m a physician. We both took the Hippocratic oath. For me, the Hippocratic oath meant that I would never harm my patients; their health and wellbeing took primacy.”
Cassidy sought assurance that Schwartz, if confirmed, would retain control over staffing at the CDC, a question that Schwartz wavered over. After several rounds of back-and-forth, the senator said he felt he was “having to go after this question a little bit more firmly” than he felt he should have.
While Schwartz reiterated she would lead with integrity and “never compromise on the science,” Cassidy said her responses were “not quite the direct answer” he’d been hoping for. Schwartz said she had pushed back against her superiors in the past, including when she worked for the U.S. Coast Guard.
In his final remarks to Schwartz, Cassidy said, “We spoke as two doctors, and here I spoke as I felt like you were always trying not to answer my question, which was disappointing.”
Cassidy, a strong proponent of immunizations, including the hepatitis B vaccine in particular, took issue with Kaufman’s past social media post that questioned the need for the hepatitis B infant dose.
In a since-deleted LinkedIn post, Kaufman wrote, “Most parents aren’t letting their babies run around practicing high-risk sexual behaviors or sharing needles. So, what’s the rush? Why is this standard practice in the U.S.?”
Cassidy derided Kaufman’s writing as “either uninformed or deliberately misleading,” slamming his hand on the dais and half-shouting, “Why would you repeat those damn lies?”
Kaufman insisted to Cassidy that he was a believer in vaccines and that he was not trying to link immunizations to autism or allergies, adding that all three of his children had received a birth dose of the hepatitis B vaccine.
Democrats unmoved
Democrats on the committee sought to determine whether Schwartz would have enough “backbone” to stand up to the administration if needed, seemingly looking for a director who would be unyielding like Monarez.
Sen. Bernie Sanders (I-Vt.), ranking member on the HELP Committee, similarly sought to find out whether the nominees would stand up to the president and Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. if needed. He asked Schwartz if she would tell Congress if the administration asked her to implement policies that were “unscientific and could harm the health and wellbeing of the American people.”
“I do not believe that the president or the secretary would ever do what you just mentioned,” Schwartz responded.
Following up on this line of questioning, Sen. Tim Kaine (D-Va.) noted that Monarez had made similar statements during her confirmation hearing, saying she believed Trump would never ask her to break the law.
Kaine said he voted against Monarez at the time because he believed she hadn’t demonstrated enough “backbone” — something he apologized for after she was fired.
“Your answer was almost exactly the same as hers. ‘I don’t think I’ll ever get asked to do such a thing,’” Kaine said.
Sen. Patty Murray (D-Wash.) said their questions were not hypothetical given what Monarez had told senators last year and asked Schwartz if she would defy Kennedy if necessary.
Schwartz avoided directly responding to Murray, saying, “I will follow the science wherever it leads, senator. You have my commitment on that.”
Infectious diseases hang heavy over hearing
Members of the committee emphasized the need for strong leadership at both the CDC and the ASPR due to the spread of measles and cyclosporiasis domestically, as well as the massive Ebola outbreak in Africa.
Murray asked Schwartz if she believed there was a scientific or medical justification for the CDC removing cyclosporiasis from its mandatory reporting program last year.
Schwartz said she was unaware of its removal but would look into it if confirmed.
Sen. Lisa Blunt Rochester (D-Del.) asked Schwartz for her thoughts on the administration’s vaccine policies, including what she characterized as a lack of outreach when it came to measles vaccinations as well as the push to reduce the childhood immunization schedule.
Schwartz told the senator that she would encourage measles vaccinations and would also examine whether changing the childhood immunization schedule, modeling it after Denmark’s, made sense.
Republican Sen. Roger Marshall (Kan.), one of the other physicians on the HELP Committee, asked Kaufman how he would handle another potential epidemic, including if he would commit to giving Americans access to “whatever vaccine” that Kaufman deems “safe and worthy.”
After some back-and-forth, Kaufman said, “Absolutely, 100 percent.”
President Trump has also nominated Sean Slovenski to be the CDC’s CEO, Jennifer Shuford to be the CDC’s chief medical officer, and Sara Brenner to be Health and Human Services Secretary Robert F. Kennedy Jr.’s senior counselor for Public Health. Their turns in front of Cassidy's firing squad have not yet been scheduled.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.























